NASDAQ:CYRX - CryoPort Stock Price, Forecast & News

CryoPort trades on the NASDAQ under the ticker symbol "CYRX."

CryoPort Inc (NASDAQ:CYRX) announced its quarterly earnings results on Thursday, November, 7th. The consumer goods maker reported ($0.05) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.07) by $0.02. The consumer goods maker earned $9.58 million during the quarter, compared to analysts' expectations of $9.49 million. CryoPort had a negative return on equity of 26.50% and a negative net margin of 64.63%. The firm's quarterly revenue was up 81.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($0.07) EPS. View CryoPort's Earnings History.

CryoPort is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for CryoPort.

CryoPort will be holding an earnings conference call on Thursday, March 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

CryoPort issued an update on its FY 2019 After-Hours earnings guidance on Thursday, January, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $33.9-33.9 million, compared to the consensus revenue estimate of $35.11 million.

5 brokerages have issued 12-month target prices for CryoPort's stock. Their forecasts range from $21.00 to $24.00. On average, they anticipate CryoPort's share price to reach $22.75 in the next twelve months. This suggests a possible upside of 42.4% from the stock's current price. View Analyst Price Targets for CryoPort.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CryoPort in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CryoPort.

News headlines about CYRX stock have been trending extremely negative on Friday, InfoTrie Sentiment reports. The research group identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. CryoPort earned a coverage optimism score of -4.4 on InfoTrie's scale. They also assigned media stories about the consumer goods maker a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for CryoPort.

Some companies that are related to CryoPort include Forward Air (FWRD), Hub Group (HUBG), Echo Global Logistics (ECHO), Roadrunner Transportation Systems (RRTS) and Sino-Global Shipping America (SINO).

Based on aggregate information from My MarketBeat watchlists, some companies that other CryoPort investors own include Gilead Sciences (GILD), Exelixis (EXEL), Micron Technology (MU), Antares Pharma (ATRS), bluebird bio (BLUE), ACADIA Pharmaceuticals (ACAD), Advanced Micro Devices (AMD), Amarin (AMRN), Clovis Oncology (CLVS) and Zynga (ZNGA).

CryoPort's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Fred Alger Management LLC (13.01%), Victory Capital Management Inc. (6.55%), Victory Capital Management Inc. (5.77%), Chevy Chase Trust Holdings Inc. (3.71%), State Street Corp (3.29%) and Janus Henderson Group PLC (1.46%). Company insiders that own CryoPort stock include Jerrell Shelton, Richard J Berman and Robert Stefanovich. View Institutional Ownership Trends for CryoPort.

CYRX stock was sold by a variety of institutional investors in the last quarter, including Chevy Chase Trust Holdings Inc., Axiom International Investors LLC DE, Bank of Montreal Can, SG Americas Securities LLC, Cubist Systematic Strategies LLC, Taylor Wealth Management Partners, Penbrook Management LLC and Braun Stacey Associates Inc.. Company insiders that have sold CryoPort company stock in the last year include Richard J Berman and Robert Stefanovich. View Insider Buying and Selling for CryoPort.

CYRX stock was bought by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Victory Capital Management Inc., State Street Corp, Handelsbanken Fonder AB, Roubaix Capital LLC, Victory Capital Management Inc., Fred Alger Management LLC and Bullseye Asset Management LLC. View Insider Buying and Selling for CryoPort.

Shares of CYRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CYRX stock can currently be purchased for approximately $15.98.

CryoPort has a market capitalization of $572.72 million and generates $19.63 million in revenue each year. The consumer goods maker earns $-9,560,000.00 in net income (profit) each year or ($0.31) on an earnings per share basis. View Additional Information About CryoPort.

The official website for CryoPort is http://www.cryoport.com/.

CryoPort's mailing address is 17305 DAIMLER STREET, IRVINE CA, 92614. The consumer goods maker can be reached via phone at 949-470-2300 or via email at [email protected]